Elmet Group Co reports results for the quarter ended June 30 - Earnings Summary
Elmet Group Co reports results for the quarter ended June 30 - Earnings Summary
Elmet Group Co ELMT.OQ reported quarterly adjusted earnings of 18 cents per share for the quarter ended June 30. The mean expectation of three analysts for the quarter was for earnings of 6 cents per share. Wall Street expected results to range from 4 cents to 7 cents per share.
Revenue was $66.40 million; analysts expected $58.12 million.
Elmet Group Co's reported EPS for the quarter was a loss of 16 cents.
The company reported a quarterly loss of $4.49 million.
Elmet Group Co shares had fallen by 14.2% this quarter.
FORECAST CHANGES
In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.
RECOMMENDATIONS
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 4 "strong buy" or "buy," no "hold" and no "sell" or "strong sell." The average consensus recommendation for the industrial machinery & equipment peer group is also "buy"
Wall Street's median 12-month price target for Elmet Group Co is $20.50, about 17.4% above its last closing price of $16.93
This summary was machine generated from LSEG data August 13 at 01:31 p.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING | ESTIMATE | ACTUAL | BEAT, MET, MISSED |
Jun. 30 2026 | 0.06 | 0.18 | Beat |
Recent news on Elmet
See all newsEU seeks closer Vietnam ties on critical minerals in China hedge, documents show
US RESEARCH ROUNDUP-Affiliated Managers Group, Goldman Sachs, Vaxcyte
Vietnam's Masan High-Tech seeks approval for 5% private placement to fund tungsten expansion
American Battery gains after export license approval
U.S. STOCKS ON THE MOVE-Pyxis Oncology, MongoDB, United Therapeutics